Inactive Instrument

News Emmaus Life Sciences, Inc. Other OTC

Equities

EMMA

US29137T1016

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Emmaus Life Sciences Reports Delayed Filing of Annual Report	Apr. 15	PR
Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico	Feb. 02	PR
Emmaus Life Sciences, Inc. Receives Marketing Authorization from the Puerto Rico Department of Health for Endari® (L-Glutamine Oral Powder)	Feb. 02	CI
Emmaus Life Sciences : Material Agreement - Form 8-K	Dec. 20	PU
Earnings Flash (EMMA) EMMAUS LIFE SCIENCES Posts Q3 Revenue $5M	Nov. 14	MT
Emmaus Life Sciences Reports Q3 2023 Financial Results	Nov. 14	PR
Emmaus Life Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Emmaus Life Sciences, Inc. Announces Board Changes	23-10-04	CI
Emmaus Life Sciences Reports Management Changes	23-08-23	PR
Emmaus Life Sciences, Inc. Announces Yutaka Niihara No Longer Serve as Chief Executive Officer	23-08-23	CI
Emmaus Life Sciences, Inc. Announces Management Changes	23-08-23	CI
Emmaus Life Sciences Reports Q2 2023 Financial Results	23-08-14	PR
Emmaus Life Sciences : Reports Q2 2023 Financial Results - Form 8-K	23-08-14	PU
Emmaus Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman	23-07-13	PR
Emmaus Life Sciences, Inc Receives Marketing Authorization for EndariÂ® in Oman	23-07-13	CI
Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA	23-05-31	PR
Emmaus Life Sciences, Inc. Receives Medicine Registration Certificate from the Bahrain National Health Regulatory Authority	23-05-31	CI
Emmaus Life Sciences, Inc. Receives Medicine Registration Certificate from the Bahrain National Health Regulatory Authority	23-05-31	CI
Earnings Flash (EMMA) EMMAUS LIFE SCIENCES Posts Q1 Revenue $6.8M	23-05-15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Emmaus Life Sciences, Inc. Other OTC

Equities

EMMA

US29137T1016

Summary

Filters